drugset / Trial / NCT00980629

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

NCT00980629 ↗

Phase 2 Completed Maruho Co., Ltd.
RandomizedDouble-blind

Summary

This study is to investigate the efficacy and safety of M516102 and to evaluate the dose response relationship of M516102 and placebo, in the treatment of pruritus associated with atopic dermatitis.

Timeline

Start
2008-08
Primary completion
—
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject M516102 Unknown — —

Indications